Nestle   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cham Switzerland (1866)
Status: No NME R&D (1866)

Organization Overview

First Clinical Trial
1995
NCT01300130
First Marketed Drug
1980
iophendylate (Pantopaque)
First NDA Approval
1980
iophendylate (Pantopaque)
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Global Development Lead - GI care | Global Medical Affairs, Société des Produits Nestlé S.A., Vevey, Switzerland | Nestec Ltd. | Nestle | Nestlé | Nestle HealthCare Nutrition | Nestle Health Science | Nestle Health Science (China) Ltd. | Nestle Health Science, Medical Director | Nestlé Health Science Spain | Nestle Nutrition | Nestlé Portugal SA | NESTLE RESEARCH | Nestlé Research | Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland | Purina Petcare | Société des Produits Nestlé S.A./CIL | Société des Produits Nestlé S.A./NIHS | Société des Produits Nestlé (SPN)